STX — Shield Therapeutics Share News
0.000.00%
- £55.86m
- £68.28m
- $49.70m
Shield Therapeutics - Notice of Results and Change in reporting currency
Shield Therapeutics Jupiter Fund Mgmt - Holding(s) in Company
Brief: Shield Therapeutics Provides Business Update And U.S. Q2 2023 Highlights
Shield Therapeutics - Business Update and U.S. Q2 2023 Highlights
Europe Research Roundup: Acciona Energia, Burberry Group, Relx
Brief: AOP Health International Says Offer For Shield Therapeutics Has Lapsed
AOP Health Intnl. Shield Therapeutics - Lapse of Offer
AOP Health Intnl. Shield Therapeutics - Acceptance Level Update
AOP Health Intnl. Shield Therapeutics - Acceptance Level Update
AOP Health Intnl. Shield Therapeutics - Acceptance Level Update
AOP Health Intnl. Shield Therapeutics - Acceptance Level Update
AOP Health Intnl. Shield Therapeutics - Acceptance Level Update
AOP Health Intnl. Shield Therapeutics - Acceptance Level Update
Shield Therapeutics - Grant of share options to the CEO
Shield Therapeutics - Holding(s) in Company
Shield Therapeutics - Holding(s) in Company
AOP Health Intnl. Shield Therapeutics - Publication and posting of Offer Document
Brief: AOP Health Proposes Deal For Shield Shareholders To Receive 6.2p In Cash For Each Shield Share
AOP Health Intnl. Shield Therapeutics - AOP Loan Conversion and Mandatory Cash Offer